Cheelcare Inc. CHCRF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.27% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.27% | -- |
| Cost of Revenue | -- | -- | -- | 36.16% | -- |
| Gross Profit | -- | -- | -- | -29.89% | -- |
| SG&A Expenses | -- | -- | -- | 70.59% | -- |
| Depreciation & Amortization | -- | -- | -- | 1,580.36% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 61.88% | -- |
| Operating Income | -- | -- | -- | -271.61% | -- |
| Income Before Tax | -- | -- | -- | -400.37% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -- | -400.37% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -400.37% | -- |
| EBIT | -- | -- | -- | -271.61% | -- |
| EBITDA | -- | -- | -- | -247.42% | -- |
| EPS Basic | -- | -- | -- | -5.85% | -- |
| Normalized Basic EPS | -- | -- | -- | -5.87% | -- |
| EPS Diluted | -- | -- | -- | -5.85% | -- |
| Normalized Diluted EPS | -- | -- | -- | -5.87% | -- |
| Average Basic Shares Outstanding | -- | -- | -- | 431.96% | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | 431.96% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |